Dexcom G7 Guide De L'utilisateur page 26

Partage avec les supporters
Certaines personnes constatent une augmentation de leur qualité de vie et de leur
tranquillité d'esprit lors de l'utilisation de la MCG en temps réel (Polonsky et Fortmann
2020). Share peut les améliorer pour les patients, leurs soignants et leur équipe de
soutien, car les Suiveurs peuvent être avertis en partageant à distance les mesures et
les alertes du capteur.
Références
Price D, Walker T. The Rationale for Continuous Glucose Monitoring-based Diabetes
Treatment Decisions and Non-adjunctive Continuous Glucose Monitoring Use. Eur
Endocrinol. 2016;12(1):24-30. doi:10.17925/EE.2016.12.01.24
Beck, R (2017). Effect of continuous glucose monitoring on glycemic control in adults
with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial.
JAMA, 317(4):371-378. doi:10.1001/jama.2016.19975
The Diabetes Control and Complications Trial Research Group. (1993). The effect of
intensive treatment of diabetes on the development and progression of long-term
complications in insulin-dependent diabetes mellitus. N Engl J Med, 329:977-986.
Lind, M (2017). Continuous glucose monitoring vs conventional therapy for glycemic
control in adults with type 1 diabetes treated with multiple daily insulin injections: the
gold randomized clinical trial.JAMA, 317(4):379-387. doi:10.1001/jama.2016.19976.
Pettus, J (2015). How patients with type 1 diabetes translate continuous glucose
monitoring data into diabetes management decisions. Endocr Pract, 21(6):613-620.
doi: 10.4158/EP14520.OR.
Polonsky WH and Fortmann AL. Impact of Real-Time Continuous Glucose Monitoring
Data Sharing on Quality of Life and Health Outcomes in Adults with Type 1 Diabetes.
Diabetes Technol Ther 2020. doi: 10.1089/dia.2020.0466.
Wadwa RP, Laffel LM, Shah VN, Garg SK. Accuracy of a factory-calibrated, real-time
continuous glucose monitoring system during 10 days of use in youth and adults with
diabetes. Diabetes Technol Ther. 2018;20(6):395-402.
18